4.25
price up icon1.19%   0.05
 
loading
Precedente Chiudi:
$4.20
Aprire:
$4.19
Volume 24 ore:
106.99K
Relative Volume:
0.78
Capitalizzazione di mercato:
$1.47B
Reddito:
$842.96M
Utile/perdita netta:
$-185.63M
Rapporto P/E:
-8.0814
EPS:
-0.5259
Flusso di cassa netto:
$-228.52M
1 W Prestazione:
+4.17%
1M Prestazione:
+7.05%
6M Prestazione:
+2.16%
1 anno Prestazione:
-12.55%
Intervallo 1D:
Value
$4.15
$4.29
Intervallo di 1 settimana:
Value
$4.12
$4.3299
Portata 52W:
Value
$2.84
$5.6405

Evotec Se Adr Stock (EVO) Company Profile

Name
Nome
Evotec Se Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
4,766
Name
Cinguettio
Name
Prossima data di guadagno
2025-04-17
Name
Ultimi documenti SEC
Name
EVO's Discussions on Twitter

Confronta EVO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
EVO
Evotec Se Adr
4.24 1.47B 842.96M -185.63M -228.52M -0.5259
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
15.11 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.43 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.35 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.38 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.64 20.17B 16.54B -1.64B 749.00M -1.45

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-24 Aggiornamento Deutsche Bank Sell → Hold
2024-10-07 Downgrade Jefferies Buy → Hold
2024-08-08 Downgrade Deutsche Bank Hold → Sell
2024-07-29 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-07-11 Downgrade Deutsche Bank Buy → Hold
2024-04-12 Aggiornamento Deutsche Bank Hold → Buy
2024-01-18 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-06-23 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-06-16 Downgrade BofA Securities Buy → Neutral
2023-06-08 Aggiornamento Citigroup Neutral → Buy
2023-04-04 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2022-12-09 Iniziato H.C. Wainwright Buy
2022-11-16 Downgrade Deutsche Bank Buy → Hold
2022-08-10 Downgrade Morgan Stanley Overweight → Underweight
2022-03-02 Ripresa Cowen Outperform
2022-01-07 Ripresa Citigroup Neutral
Mostra tutto

Evotec Se Adr Borsa (EVO) Ultime notizie

pulisher
Jun 04, 2025

8 New 4-Star Stocks - Morningstar

Jun 04, 2025
pulisher
May 24, 2025

Evotec SE ADR (EVO) Strikes $4.73: The Risk Seems Worthwhile At This Price - Stocksregister

May 24, 2025
pulisher
May 10, 2025

Evotec SE (EVO) Stock Forecasts - Yahoo Finance

May 10, 2025
pulisher
May 07, 2025

Evotec SE ADR earnings missed by $0.03, revenue fell short of estimates - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Evotec Ag Earnings Call: Mixed Sentiment Amid Growth - TipRanks

May 07, 2025
pulisher
May 07, 2025

Evotec AG Reports Q1 2025 Earnings and Strategic Progress - TipRanks

May 07, 2025
pulisher
Apr 28, 2025

Stock Information - Evotec

Apr 28, 2025
pulisher
Apr 24, 2025

Evotec shares surge 51% following InvestingPro’s undervalued signal By Investing.com - Investing.com

Apr 24, 2025
pulisher
Apr 18, 2025

Evotec SE ADR earnings beat by $0.08, revenue topped estimates - Investing.com Australia

Apr 18, 2025
pulisher
Apr 17, 2025

Evotec SE Reports Strong Q4 2024 and New Strategy - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec Ag’s Earnings Call: Growth Amid Challenges - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec: Management Streamlines Strategy to Refocus on Core Strengths Amid Biologics Momentum - Morningstar

Apr 17, 2025
pulisher
Apr 11, 2025

Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts - GlobeNewswire Inc.

Apr 11, 2025
pulisher
Dec 29, 2024

Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha

Dec 29, 2024
pulisher
Dec 27, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - MSN

Dec 27, 2024
pulisher
Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024
pulisher
Nov 22, 2024

Evotec SE withdraws acquisition offer - Investing.com

Nov 22, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 17, 2024

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says - BNN Bloomberg

Nov 17, 2024
pulisher
Nov 14, 2024

Halozyme proposes $2 billion acquisition of Evotec - Investing.com

Nov 14, 2024
pulisher
Nov 06, 2024

Evotec Reports Strategic Growth Amidst Revenue Challenges - TipRanks

Nov 06, 2024
pulisher
Aug 23, 2024

Annual General Meeting - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Investor Relations - Evotec

Aug 23, 2024
pulisher
Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar

Aug 13, 2024
pulisher
Jun 06, 2024

Healthcare Sector - Morningstar

Jun 06, 2024
pulisher
May 23, 2024

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges - Investing.com

May 23, 2024
pulisher
Apr 24, 2024

Evotec: Still A Speculative Buy After A Significant Decline (NASDAQ:EVO) - Seeking Alpha

Apr 24, 2024
pulisher
Nov 10, 2022

Evotec SE ADR earnings, Revenue miss in Q3 By Investing.com - Investing.com India

Nov 10, 2022
pulisher
Jun 15, 2022

Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J - Yahoo Finance

Jun 15, 2022
pulisher
Jan 21, 2012

Together for Medicines That MatterEvotec - Evotec

Jan 21, 2012
pulisher
May 11, 2010

Evotech and Roche subsidiary Genentech enter into drug discovery alliance - Proactive Investors USA

May 11, 2010
pulisher
Sep 09, 2009

Evotec and Biogen Idec in research agreement - Proactive financial news

Sep 09, 2009

Evotec Se Adr Azioni (EVO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$14.43
price up icon 0.92%
$9.11
price up icon 2.07%
$127.93
price up icon 1.78%
$290.03
price up icon 0.95%
drug_manufacturers_specialty_generic RDY
$14.93
price down icon 0.65%
$16.64
price down icon 0.66%
Capitalizzazione:     |  Volume (24 ore):